Glioquell is a biopharmaceutical company focused on developing innovative therapies for patients with neuro-oncological conditions, specifically targeting glioblastoma multiforme (GBM). The company is dedicated to advancing treatments that improve patient outcomes and enhance the quality of life for those affected by this aggressive form of brain cancer.